Difference between revisions of "Migden MR, et al. N. Engl. J. Med. (2018) cited as Ref 638 in DOI: 10.1038/s41392-020-0110-5 (Q9901)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: First Author string (P149): Migden MR, #quickstatements; #temporary_batch_1589996169159)
(‎Created claim: Page(s) (P105): 341-351, #quickstatements; #temporary_batch_1590074839150)
 
(6 intermediate revisions by the same user not shown)
Property / DOI Identifier
 +
Property / DOI Identifier: 10.1056/NEJMoa1805131 / rank
 +
Normal rank
Property / PubMed ID
 +
Property / PubMed ID: 29863979 / rank
 +
Normal rank
Property / Publication Date
 +
2018
Timestamp+2018-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2018 / rank
 +
Normal rank
Property / Published In Name String
 +
N. Engl. J. Med.
Property / Published In Name String: N. Engl. J. Med. / rank
 +
Normal rank
Property / Volume
 +
379
Property / Volume: 379 / rank
 +
Normal rank
Property / title
 +
PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma (English)
Property / title: PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma (English) / rank
 +
Normal rank
Property / Page(s)
 +
341-351
Property / Page(s): 341-351 / rank
 +
Normal rank

Latest revision as of 15:47, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Migden MR, et al. N. Engl. J. Med. (2018) cited as Ref 638 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Migden MR
    0 references
    0 references
    2018
    0 references
    N. Engl. J. Med.
    0 references
    379
    0 references
    PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma (English)
    0 references
    341-351
    0 references